167 related articles for article (PubMed ID: 37496220)
1. [Ⅰ. Photo-Immunotherapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck].
Sano D; Oridate N
Gan To Kagaku Ryoho; 2023 Jul; 50(7):775-780. PubMed ID: 37496220
[No Abstract] [Full Text] [Related]
2. New insights into CAR T-cell therapy for recurrent head and neck squamous cell carcinoma.
Sankar S
Oral Oncol; 2022 Nov; 134():106137. PubMed ID: 36174455
[No Abstract] [Full Text] [Related]
3. The biology of combination immunotherapy in recurrent metastatic head and neck cancer.
Yuan X; Yi M; Zhang W; Xu L; Chu Q; Luo S; Wu K
Int J Biochem Cell Biol; 2021 Jul; 136():106002. PubMed ID: 33962022
[TBL] [Abstract][Full Text] [Related]
4. Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer.
Le X; Ferrarotto R; Wise-Draper T; Gillison M
J Natl Compr Canc Netw; 2020 Jul; 18(7):899-906. PubMed ID: 32634775
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
[TBL] [Abstract][Full Text] [Related]
6. Durable complete response rates following radiotherapy and immunotherapy combination in recurrent and metastatic head and neck squamous cell carcinoma: A retrospective single-centre cohort study.
Khera R; Feeney L; Swinton M; Rack S; Sykes A; Metcalf R
Clin Otolaryngol; 2022 Sep; 47(5):606-610. PubMed ID: 35737806
[No Abstract] [Full Text] [Related]
7. ["Immunotherapy in head and neck squamous cell carcinoma"].
Marret G; Borcoman É; Le Tourneau C
Rev Prat; 2021 Apr; 71(4):396-399. PubMed ID: 34161005
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: Expecting Its Application in Temporal Bone Squamous Cell Carcinoma.
Shi MW; Huang J; Sun Y
Curr Med Sci; 2023 Apr; 43(2):213-222. PubMed ID: 36971976
[TBL] [Abstract][Full Text] [Related]
9. Managing Recurrent Metastatic Head and Neck Cancer.
Shaikh H; Karivedu V; Wise-Draper TM
Hematol Oncol Clin North Am; 2021 Oct; 35(5):1009-1020. PubMed ID: 34226077
[TBL] [Abstract][Full Text] [Related]
10. Locoregional recurrence of an HPV-positive squamous cell carcinoma of the head and neck.
Bowles DW; Reddy K; Wine T; Ree A; Raben D; Chen C; Jimeno A
Oncology (Williston Park); 2011 Oct; 25(11):1042-8. PubMed ID: 22106555
[No Abstract] [Full Text] [Related]
11. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
Front Immunol; 2021; 12():652054. PubMed ID: 34305889
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for squamous cell carcinoma of the head and neck.
Yokota T; Homma A; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ogawa T; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Tanaka K; Onoe T; Okano S; Imamura Y; Ariizumi Y; Hayashi R;
Jpn J Clin Oncol; 2020 Sep; 50(10):1089-1096. PubMed ID: 32776100
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature.
Bossi P; Alfieri S; Strojan P; Takes RP; López F; Mäkitie A; Saba NF; Rodrigo JP; Bradford C; Suarez C; Zafereo M; Forastiere AA; Vermorken JB; Quer M; Sanabria A; Simo R; de Bree R; Rinaldo A; Ferlito A
Crit Rev Oncol Hematol; 2019 May; 137():84-91. PubMed ID: 31014517
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2018 ASCO meeting].
Bußmann L; Münscher A; Busch CJ
HNO; 2018 Dec; 66(12):907-912. PubMed ID: 30377743
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy for head and neck squamous cell carcinoma].
Lecocq M; Poncin A; Sautois B
Rev Med Liege; 2021 May; 76(5-6):398-402. PubMed ID: 34080370
[TBL] [Abstract][Full Text] [Related]
16. Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects.
Ganly I; Kaye SB
Ann Oncol; 2000 Jan; 11(1):11-6. PubMed ID: 10690381
[TBL] [Abstract][Full Text] [Related]
17. Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma.
Zhang X; Wang P; Chai Y; Zhou X; Li P; Wang X
Am J Otolaryngol; 2024; 45(1):104065. PubMed ID: 37879241
[TBL] [Abstract][Full Text] [Related]
18. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
[TBL] [Abstract][Full Text] [Related]
19. [Overview and prospects of neoadjuvant immunotherapy in head and neck squamous cell carcinoma].
Liu SY; Song YX; Zhu YM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):301-305. PubMed ID: 38599644
[TBL] [Abstract][Full Text] [Related]
20. Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
Belgioia L; Becherini C; Bacigalupo A; Bonomo P
Oral Oncol; 2022 Apr; 127():105773. PubMed ID: 35217401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
